๐™ˆ๐™” REGN ๐™‘๐˜ผ๐™‡๐™๐˜ผ๐™๐™„๐™Š๐™‰ ๐™ˆ๐™Š๐˜ฟ๐™€๐™‡

๐™ˆ๐™” $Regeneron Pharmaceuticals(REGN)$ ๐™‘๐˜ผ๐™‡๐™๐˜ผ๐™๐™„๐™Š๐™‰ ๐™ˆ๐™Š๐˜ฟ๐™€๐™‡

1Y TARGET: $1060

POTENTIAL UPSIDE: +31% โœ…

ASSUMPTIONS:

LTM Revenue: $15.535B

5Y Revenue CAGR: 10%

2031 Profit Margin: 35%

2031 PE Ratio: 17

Shares outstanding: 106.0M

Shares reduction: 2%/year

VALUATION:

Q2 2031

$Regeneron Pharmaceuticals(REGN)$

SHARE PRICE =15.535 * (1.10)^5 * 0.35 * 17 /[0.1060 * (0.98^5)] = $1554

You can now choose the discount rate that you prefer, for Regeneron I want to use 10%.

ACTUAL PRICE: $810

FAIR VALUE: $965

PRICE TARGET (1Y): $1060

POTENTIAL UPSIDE: +31%

EXPECTED RETURNS: 13.9%/year

DIVIDEND YIELD: 0.5%

- - - - - - - - - - - - - - -

๐˜›๐˜ฉ๐˜ช๐˜ด ๐˜ฑ๐˜ฐ๐˜ด๐˜ต ๐˜ช๐˜ด ๐˜ง๐˜ฐ๐˜ณ ๐˜ช๐˜ฏ๐˜ง๐˜ฐ๐˜ณ๐˜ฎ๐˜ข๐˜ต๐˜ช๐˜ฐ๐˜ฏ๐˜ข๐˜ญ ๐˜ข๐˜ฏ๐˜ฅ ๐˜ฆ๐˜ฅ๐˜ถ๐˜ค๐˜ข๐˜ต๐˜ช๐˜ฐ๐˜ฏ๐˜ข๐˜ญ ๐˜ฑ๐˜ถ๐˜ณ๐˜ฑ๐˜ฐ๐˜ด๐˜ฆ๐˜ด ๐˜ฐ๐˜ฏ๐˜ญ๐˜บ.

๐˜'๐˜ฎ ๐˜ฏ๐˜ฐ๐˜ต ๐˜ข ๐˜ง๐˜ช๐˜ฏ๐˜ข๐˜ฏ๐˜ค๐˜ช๐˜ข๐˜ญ ๐˜ข๐˜ฅ๐˜ท๐˜ช๐˜ด๐˜ฐ๐˜ณ and all the ๐˜ช๐˜ฏ๐˜ง๐˜ฐ๐˜ณ๐˜ฎ๐˜ข๐˜ต๐˜ช๐˜ฐ๐˜ฏ ๐˜ค๐˜ฐ๐˜ฏ๐˜ต๐˜ข๐˜ช๐˜ฏ๐˜ฆ๐˜ฅ ๐˜ช๐˜ฏ ๐˜ต๐˜ฉ๐˜ช๐˜ด ๐˜ฑ๐˜ฐ๐˜ด๐˜ต ๐˜ช๐˜ด ๐˜ฏ๐˜ฐ๐˜ต ๐˜ง๐˜ช๐˜ฏ๐˜ข๐˜ฏ๐˜ค๐˜ช๐˜ข๐˜ญ ๐˜ข๐˜ฅ๐˜ท๐˜ช๐˜ค๐˜ฆ.

- - - - - - - - - - - - - - -

Do you own $Regeneron Pharmaceuticals(REGN)$ shares?

# AI Companies and Industry DIG

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment

  • Top
  • Latest
empty
No comments yet